Astellas Pharma Inc. (4503) - Financials, balance sheet (annual)

1,390.5 JPY

10.5

0.76%

Last update May 22, 3:24 PM JST

Market closed

Day range

1,390.5

1,373

1,396

Previous close

1,380

Open

1,374

Access this stock data via API

Astellas Pharma Inc.

1,390.50

10.50

0.76%

Financials

Balance sheet

Fiscal date	2024	2023	2022	2021
Total assets	3.6T	2.5T	2.3T	2.3T
Current assets	1.2T	1.0T	923.4B	872.6B
Cash	—	—	—	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	335.7B	376.8B	316.0B	326.1B
Other short term investments	28.8B	19.8B	21.3B	5.6B
Accounts receivable	535.0B	428.0B	382.5B	343.2B
Other receivables	—	—	—	—
Inventory	248.7B	174.4B	153.1B	164.1B
Prepaid assets	—	—	—	—
Restricted cash	—	—	—	—
Assets held for sale	1.2B	738M	0	—
Hedging assets	—	—	—	—
Other current assets	32.2B	32.4B	29.0B	19.7B
Non current assets	2.4T	1.4T	1.4T	1.4T
Properties	—	—	—	—
Land and improvements	—	—	—	—
Machinery furniture equipment	—	—	—	—
Construction in progress	—	—	—	—
Leases	—	—	—	—
Accumulated depreciation	—	—	—	—
Goodwill	2.3T	1.2T	1.2T	1.2T
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	1.5T	562.5B	623.4B	651.4B
Investments and advances	—	—	—	—
Other non current assets	18.6B	10.3B	9.5B	9.9B
Total liabilities	2.0T	948.6B	872.1B	887.5B
Current liabilities	1.3T	726.0B	687.4B	592.4B
Accounts payable	185.2B	140.2B	130.7B	124.8B
Accrued expenses	—	—	—	—
Short term debt	472.3B	75B	—	—
Deferred revenue	—	—	—	—
Tax payable	38.5B	5.1B	32.4B	8.4B
Pensions	—	—	—	—
Other current liabilities	476.5B	382.7B	322.8B	288.9B
Non current liabilities	687.9B	222.5B	184.7B	295.1B
Long term provisions	7.4B	6.5B	5.8B	5.8B
Long term debt	447.7B	50B	—	—
Provision for risks and charges	2.2B	4.2B	676M	400M
Deferred liabilities	51.3B	6.0B	5.8B	18.2B
Derivative product liabilities	—	—	—	—
Other non current liabilities	49.0B	41.0B	39.2B	32.8B
Shareholders equity
Common stock	103.0B	103.0B	103.0B	103.0B
Retained earnings	809.4B	908.2B	944.3B	953.3B
Other shareholders equity	—	—	—	—
Total shareholders equity	1.6T	1.5T	1.5T	1.4T
Additional paid in capital	184.1B	181.3B	179.5B	177.8B
Treasury stock	33.8B	25.1B	13.9B	15.4B
Minority interest	—	—	—	—